Investment analysts at StockNews.com initiated coverage on shares of Nu Skin Enterprises (NYSE:NUS – Get Rating) in a research note issued to investors on Thursday. The brokerage set a “hold” rating on the stock. Several other research analysts have also recently weighed in on the stock. DA Davidson decreased their price objective on shares of […]
StockNews.com lowered shares of Nu Skin Enterprises (NYSE:NUS – Get Rating) from a buy rating to a hold rating in a report released on Monday morning. A number of other equities research analysts have also recently commented on NUS. DA Davidson dropped their price objective on shares of Nu Skin Enterprises from $40.00 to $38.00 […]
Nu Skin Enterprises (NYSE:NUS – Get Rating) issued an update on its FY23 earnings guidance on Wednesday morning. The company provided EPS guidance of $2.41-2.81 for the period, compared to the consensus EPS estimate of $2.55. The company issued revenue guidance of $2.03-2.18 billion, compared to the consensus revenue estimate of $2.09 billion. Nu Skin […]
Should You Buy or Sell Nu Skin Enterprises Stock? Get The Latest NUS Stock Forecast, Price Target, Dividend Info, Headlines, Short Interest at MarketBeat.
/PRNewswire/ Nu Skin Enterprises (NYSE: NUS), a global beauty and wellness leader, today announced that its Chief Scientific Officer Dr. Joseph Y. Chang.